Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Amberg – page 5

55 clinical trials in Amberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Amberg at a glance
55
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

55 trials in Amberg

Open in trial search

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Prostate cancer

Not recruiting

Study on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Janssen Cilag International

Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sacituzumab Govitecan
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut Für Frauengesundheit GmbH

Study on Peppermint Oil and Caraway Oil for Patients with Functional Gastrointestinal Disorders

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Caraway Oil
  • Sponsor:Dr. Willmar Schwabe GmbH & Co. KG

Lung adenocarcinoma

Not recruiting

Study Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Amberg

What the registry says about research in the country

01 Oncology Research

Extensive clinical trials focusing on colorectal cancer treatments, including studies of novel drug combinations and targeted therapies for metastatic disease. Research encompasses both early-stage interventions and advanced treatment protocols.

  • Colorectal Cancer Studies
  • Gastric Cancer Treatments
  • Lung Cancer Therapies

Multiple trials evaluating immunotherapy combinations and precision medicine approaches for various cancer types.

02 Hematologic Malignancies

Innovative research in chronic lymphocytic leukemia and lymphoma, investigating novel therapeutic combinations and targeted treatments for better patient outcomes.

  • Leukemia Treatments
  • Lymphoma Studies
  • Novel Drug Combinations

Focus on personalized treatment approaches and duration optimization based on minimal residual disease monitoring.

03 Cardiovascular and Metabolic Research

Studies examining new treatments for hypercholesterolemia and investigating innovative approaches to cardiovascular disease management.

  • Cholesterol Management
  • Kidney Disease Studies
  • Hypertension Research

Trials evaluating combination therapies and novel compounds for metabolic disorders.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.